Board meeting on 27 October 2026 to consider and approve Q2 and H1 unaudited results
Piramal Pharma has informed the exchanges that its Board of Directors will meet on Tuesday, 27th October, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Tuesday, 27th October, 2026
- Agenda
- consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026
- Trading Window Closure
- closed from Thursday, 1st October, 2026 till Thursday, 29th October, 2026 (both days inclusive)
Piramal Pharma has informed the stock exchanges of the date on which its next set of financial results will be taken up by the Board.
The board meeting
- A meeting of the Board of Directors will be held on Tuesday, 27th October, 2026.
- The Board will consider and approve the Unaudited Financial Results, both Standalone and Consolidated.
- These results are for the quarter and half year ended 30th September, 2026.
Trading window
- The trading window for dealing in the securities of the company has been closed from Thursday, 1st October, 2026.
- It will remain closed till Thursday, 29th October, 2026, both days inclusive.
- The closure covers the days around the board meeting and the results.
Standalone and consolidated
- Standalone results reflect the company's own operations.
- Consolidated results bring in its subsidiaries and give the wider group picture.
- Both are being placed before the Board at the same meeting.
What a reader can take from this
- This intimation sets out a date and an agenda; the financial numbers themselves are to be approved at that meeting.
- The trading window closure is a restriction on dealing in the company's securities for the specified period, ending 29th October, 2026.
- Investors looking for the actual performance figures of the September 2026 quarter and half year would track the outcome of the meeting scheduled for 27th October, 2026.
Also from Piramal Pharma
Piramal Pharma to host Q2 and H1 FY2027 earnings conference call on 28 October 2026
16 Oct 2026
Rapid fire caller query on Piramal Pharma asking about long-term hold
13 Oct 2026
Bayer sales & distribution arrangement to expire on 31st December, 2026; will not be renewed
1 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.